Rhythm Pharmaceuticals, Inc. (RYTM)
104.72
-1.40
(-1.32%)
USD |
NASDAQ |
Sep 01, 16:00
104.72
0.00 (0.00%)
After-Hours: 17:26
Rhythm Pharmaceuticals Total Long Term Debt (Quarterly) : 109.08M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 109.08M |
| March 31, 2026 | 226.34M |
| December 31, 2025 | 242.48M |
| September 30, 2025 | 259.35M |
| June 30, 2025 | 258.96M |
| March 31, 2025 | 257.50M |
| December 31, 2024 | 256.57M |
| September 30, 2024 | 254.75M |
| June 30, 2024 | 251.82M |
| March 31, 2024 | 107.65M |
| December 31, 2023 | 106.63M |
| September 30, 2023 | 105.39M |
| June 30, 2023 | 80.24M |
| March 31, 2023 | 78.60M |
| December 31, 2022 | 77.07M |
| September 30, 2022 | 1.44M |
| June 30, 2022 | 1.614M |
| March 31, 2022 | 1.781M |
| December 31, 2021 | 1.945M |
| September 30, 2021 | 2.104M |
| June 30, 2021 | 2.258M |
| March 31, 2021 | 2.406M |
| December 31, 2020 | 2.551M |
| Date | Value |
|---|---|
| September 30, 2020 | 2.692M |
| June 30, 2020 | 2.828M |
| March 31, 2020 | 2.959M |
| December 31, 2019 | 3.086M |
| September 30, 2019 | 3.211M |
| June 30, 2019 | 3.331M |
| March 31, 2019 | 3.446M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| BioMarin Pharmaceutical, Inc. | 4.186B |
| Cytokinetics, Inc. | 1.250B |
| Exelixis, Inc. | 165.93M |